Lotrel and Nplate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lotrel (amlodipine besylate; benazepril hydrochloride) and Nplate (romiplostim). Common drug interactions include contusion among females and drug ineffective among males.

The phase IV clinical study analyzes what interactions people have when they take Lotrel and Nplate. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Lotrel?

Lotrel has active ingredients of amlodipine besylate; benazepril hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 13,571 Lotrel users. Check the latest studies of Lotrel.

What is Nplate?

Nplate has active ingredients of romiplostim. It is often used in idiopathic thrombocytopenic purpura (itp). eHealthMe is studying from 17,850 Nplate users. Check the latest studies of Nplate.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 25, 2026

15 people who take Lotrel and Nplate together, and have interactions are studied.

Lotrel and Nplate drug interactions.

What are the common drug interactions of Lotrel and Nplate, by gender? *:

female:

  1. Contusion (a type of hematoma of tissue in which capillaries)
  2. Therapeutic response decreased (less preventive response)
  3. Thrombocytosis
  4. Drug ineffective
  5. Bone pain
  6. Fatigue (feeling of tiredness)
  7. Herpes zoster
  8. Pain
  9. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  10. Rash

male:

  1. Drug ineffective
  2. Anaemia (lack of blood)
  3. Hypoaesthesia (reduced sense of touch or sensation)
  4. Insomnia (sleeplessness)
  5. Weight decreased
  6. Bone marrow disorder
  7. Chronic kidney disease
  8. Contusion (a type of hematoma of tissue in which capillaries)
  9. Drug effect decreased
  10. Ecchymosis (a discoloration of the skin resulting from bleeding underneath)

What are the common drug interactions of Lotrel and Nplate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Bone pain
  2. Contusion (a type of hematoma of tissue in which capillaries)
  3. Fatigue (feeling of tiredness)
  4. Herpes zoster
  5. Pain
  6. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  7. Rash
  8. Sinus congestion (blockage of sinus)
  9. Therapeutic response decreased (less preventive response)
  10. Thrombocytopenia (decrease of platelets in blood)

40-49:

n/a

50-59:

n/a

60+:

  1. Drug ineffective
  2. Thrombocytosis
  3. Ecchymosis (a discoloration of the skin resulting from bleeding underneath)
  4. Fatigue (feeling of tiredness)
  5. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  6. Helicobacter infection (helicobacter pylori (h. pylori) infects stomach)
  7. Hypoaesthesia (reduced sense of touch or sensation)
  8. Insomnia (sleeplessness)
  9. Weight decreased
  10. Contusion (a type of hematoma of tissue in which capillaries)

What are the existing conditions these people have? *

  1. Idiopathic Thrombocytopenic Purpura (bleeding disorder in which the immune system destroys platelets, which are necessary for normal blood clotting): 14 people, 93.33%

* Approximation only. Some reports may have incomplete information.

Do you take Lotrel and Nplate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lotrel and Nplate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lotrel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Nplate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lotrel and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nplate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on amlodipine besylate; benazepril hydrochloride and romiplostim (the active ingredients of Lotrel and Nplate, respectively), and Lotrel and Nplate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: